Zyomyx Closes Series 2 Preferred Financing Round of $12 Million to Enable Launch of Low-Cost, Rapid Point-of-Care CD4 Test FREMONT, Calif., June 30, 2013 (GLOBE NEWSWIRE) -- Zyomyx, Inc. announced today that it completed the first closing of its Series 2 Preferred financing totaling US$12 million. The financing was led by...

Zyomyx, Inc. Announces Appointment of Chief Financial Officer FREMONT, Calif., Sept. 24, 2012 (GLOBE NEWSWIRE) -- Zyomyx, Inc., an innovator in the development and commercialization of proprietary diagnostic platforms, has appointed Jennifer McFarlane as Chief...